跳至主要内容
临床试验/NL-OMON53015
NL-OMON53015尚未招募2 期

Amoxicillin-clavulanic acid Levels in Sputum After Nebulization in AECOPD (ALSAN) - ALSA

Medisch Spectrum Twente0 个研究点目标入组 21 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1) A clinical diagnosis of COPD, as defined by GOLD criteria
  • 2) Hospitalized for an acute exacerbation of COPD
  • 3) Admitted to the ward of pulmonary medicine
  • 4) Age 40 years or over
  • 5) Current or former smoker

排除标准

  • 1) Current pneumonia, defined as an acute respiratory tract illness associated
  • with radiographic shadowing on a X-ray or CT-scan of the chest which was
  • neither pre-existing nor of any other cause.
  • 2) Allergy for penicillin, amoxicillin or clavulanic acid.
  • 3) Recently diagnosed or unresolved lung malignancy
  • 4) amoxicillin or clavulanic acid therapy within 3 days prior to admission,
  • During the trial the patient cannot be treated with systemic amoxicillin or
  • amoxicillin clavulanic acid.

研究者

相似试验

Amoxicillin-clavulanic acid Levels in Sputum After... | 临床试验